Vice President, R&D Diagnostics and Clinical Development at ArcherDX - Boulder, CO, US
Executive Vice President, Commercial Operations
ArcherDX, Inc., creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types. By combining novel enrichment chemistry, automated informatics and a user-friendly workflow, Archer® products remove the bottlenecks associated with using next-gen sequencing in a translational setting.